Renita Brown
Infectious Disease · Indianapolis, INNPI 1881766475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 453 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Among infectious disease clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 453 payments — averaging $25.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Phathom Pharmaceuticals, Inc.$960
- Gilead$594
- plus $4K from 24 others
What the payments were for
- Food & beverage$11,51699%
- Education$1321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 63 | $2,220 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 118 | $1,910 |
| Johnson & Johnson | 45 | $1,240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $1,024 |
| Phathom Pharmaceuticals, Inc. | 29 | $960 |
| Gilead | 20 | $594 |
| E.r. Squibb & Sons, L.L.C. | 5 | $569 |
| Ardelyx, Inc. | 15 | $412 |
| Braintree Laboratories, Inc. | 22 | $369 |
| Pfizer | 9 | $349 |
| Merck | 12 | $237 |
| Celltrion USA Inc. | 9 | $228 |
| Janssen Scientific Affairs, LLC | 3 | $223 |
| Nestle Healthcare Nutrition Inc. | 13 | $222 |
| Regeneron Healthcare Solutions, Inc. | 8 | $189 |
| Redhill Biopharma Inc. | 6 | $179 |
| Ironwood Pharmaceuticals, Inc | 10 | $178 |
| Novo Nordisk | 2 | $142 |
| Lilly USA, LLC | 4 | $103 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Intercept Pharmaceuticals, Inc. | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| QOL Medical, LLC | 2 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Medtronic | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $14 |
| Shionogi Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,648 in reported general payments places this provider in the 90th percentile of 152 infectious disease providers in Indiana.
Other infectious disease in Indianapolis
- Samir GuptaIndianapolis$53K
- Darron BrownIndianapolis$21K
- Stephen JordanIndianapolis$3K
- Bree WeaverIndianapolis$2K
- Steven NorrisIndianapolis$2K
- Kathryn RobertsonIndianapolis$1K
- Christina TangIndianapolis$1K
- Carmen TichindeleanIndianapolis$1K
- Keith BanksIndianapolis$861
- Virginia CaineIndianapolis$643
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.